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ABSTRACT
Introduction: Adiposity has been associated with
atherosclerosis in clinical studies. However, few
autopsy studies have investigated this association, and
they had only examined the coronary artery disease.
Moreover, most studies had small sample sizes and
were limited to middle-aged or young adults. Our aim
is to investigate the association between adiposity and
systemic atherosclerosis in an autopsy study.
Methods and analysis: A sample of 240 deceased
with 30 years or more will be evaluated. The sample
size was calculated using the lowest correlation
coefficient found in previous studies (r=0.109),
assuming a power of 90% and α=0.05. We will collect
information about sociodemographics, frequency of
previous contact of the deceased’s next of kin and
cardiovascular risk factors. We will measure neck,
waist and hip circumferences, weight, height and
abdominal subcutaneous tissue thickness, and then we
will calculate the body mass index, waist-to-hip ratio,
waist-to-height ratio and body shape index. We will
also weigh the pericardial and abdominal visceral fat,
the heart, and we will measure the left ventricular wall
thickness. We will evaluate the presence of myocardial
infarction, the degree of atherosclerosis in the aorta,
carotid, coronary and cerebral arteries and plaque
composition in carotid, coronary and cerebral arteries.
For each individual, we will fix arterial and adipose
tissue samples in 10% formalin and freeze another
adipose tissue sample at −80°C for future studies.
Ethics and dissemination: Ethical approval was
granted by the Ethics Committee of University of Sao
Paulo Medical School, Brazil. Results will be submitted
for publication in a peer-reviewed journal.
INTRODUCTION
Ischaemic heart disease and stroke were the
leading causes of death worldwide in 2013
and were estimated to be responsible for
14.8% and 11.7% of all deaths, respectively.
In 2012, 14.1 million people died from these
diseases.1 2 Moreover, ischaemic heart
disease is the leading cause of DALYs
(Disability-Adjusted Life Years) in the world
(2342 per 100 000 cases), and the stroke is
the third leading cause of DALYs (1998 per
KEY QUESTIONS
What is already known about this subject?
▸ Anthropometric measurements and epicardial
and pericardial fat were associated with athero-
sclerosis in coronary and carotid arteries in
previous imaging studies.
▸ Few autopsy studies investigated the association
of atherosclerosis with anthropometric measure-
ments and visceral fat. Moreover, they did not
evaluate atherosclerosis at sites other than cor-
onary arteries, had small sample sizes, and were
limited to middle-aged or young adults.
What does this study add?
▸ We will quantify the paracardial and epicardial
fat and measure atherosclerosis severity in
carotid, aorta, cerebral, and coronary arteries
using morphometric methods in an autopsy
study with a large number of subjects from
different age groups and ethnicities.
▸ We will also investigate the association of sys-
temic atherosclerosis with a variety of anthropo-
metric measures, like “body shape index”,
abdominal subcutaneous tissue thickness, body
mass index, waist-to-hip ratio, waist-to-height
ratio, and neck and abdominal circumference.
How might this impact on clinical practice?
▸ Identifying which measure is more associated
with systemic atherosclerosis will allow to target
individuals at higher risk of cardiovascular
events.
▸ This study will provide a diverse tissue collec-
tion of arteries and visceral fat, which will be a
unique opportunity for future collaborative
studies and will contribute to advance the
understanding of the relationship between
systemic atherosclerosis and adiposity.
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100 000 cases).1 Therefore, the identification of risk
factors3 is important in preventing atherosclerosis and
decreasing the cardiovascular disease burden.
Measures of adiposity, such as anthropometrics and
thoracic and abdominal visceral fat measurements, have
been associated with atherosclerosis.4–10 However, most of
the previous studies have investigated the association
between anthropometric and/or visceral fat measure-
ments with systemic atherosclerosis using imaging
methods such as ultrasound,8 11 12 CT,5 9 10 angiography7 9
and echocardiography.7 11 In a review study of
Alexopoulos et al,13 all studies that investigated the associ-
ation of visceral adipose tissue with atherosclerosis used
imaging methods.
Several disadvantages of these methods are well known,
for instance, angiography is an invasive method that
exposes the individual to radiation; CT also exposes
patients to ionising radiation and the exact anatomical
borders of structures in non-contrasted exams are diffi-
cult to define using imaging methods,8 14 and paracardial
fat is difficult to delimit by echocardiography.15 Although
postmortem examination provides a more accurate
measure of atherosclerosis and visceral fat due to the
direct assessment of these structures, few autopsy studies
compared atherosclerosis to anthropometric measure-
ments and visceral fat.4 16–22 In addition, none of these
studies evaluated atherosclerosis at sites other than coron-
ary arteries. Most of these studies also had small sample
sizes and were limited to middle-aged or young adults.
We aim to investigate the association between adiposity
measured by the weight of the visceral fat and anthropo-
metric measurements with morphometric measures of
atherosclerosis in the aorta, coronary, carotid and cere-
bral arteries in a large sample from different age groups.
METHODS AND ANALYSIS
Study design
A cross-sectional observational study is designed.
Study setting
This study will be conducted at the Sao Paulo Autopsy
Service (SPAS), Laboratory of Cardiovascular Pathology
and the Pathophysiology in Aging Lab from the
Department of Pathology, University of Sao Paulo, Sao
Paulo, Brazil.
Since 1931, the SPAS has performed autopsies of indi-
viduals who died in the city of Sao Paulo and who have
had an unknown natural cause of death. It performs
more than 13 000 autopsies per year.23 In 2004, we
started a successful initiative at the SPAS to investigate
brain ageing and neurodegenerative diseases. The Brain
Bank of the Brazilian Aging Brain Study Group
(BB-BABSG) has collected more than 3000 brains over
the last decade to provide the materials and data for a
number of publications in high-quality international
journals.24–26 We will extend the work of the BB-BABSG
to evaluate the atherosclerosis process.
Study participants
A convenience sample of 240 deceased individuals
referred to the SPAS, and whose next of kin (NOK)
agrees to participate will be included in this study.
Inclusion criterion:
A. Individuals aged 30 years or more.
Exclusion criteria (figure 1):
A. The NOK of the deceased provides inconsistent data
during the clinical interview.
B. The NOK of the deceased does not have at least
weekly contact with the deceased.
C. There are visible evidence of factors modifying
anthropometric measures, such as ascites, severe
abdominal distension and pregnancy.
D. Loss of 10% or more of usual weight during the
6 months prior to death.
E. Arteries or visceral fat of the individuals are retained
at the autopsy by the pathologist.
F. Postmortem interval (PMI) >24 hours.
G. Signs of body autolysis, according to the Crossley
criteria.27
Outcome measures
The primary outcome of interest will be atherosclerosis
that is measured by the stenosis index in coronary,
carotid and cerebral arteries and by the degree of ath-
erosclerosis in the aorta. The secondary outcome will be
the number of atherosclerotic plaques in cerebral and
coronary arteries. All outcomes will be measured after
autopsy.
Data collection
The NOK of the deceased will answer a semistructured
clinical interview that will be administered by trained
nurses concerning sociodemographics (age, gender,
race, marital status, schooling and socioeconomic status
(SES)), frequency of his/her previous contact with the
deceased (weekly or daily) and cardiovascular risk
factors (hypertension, diabetes mellitus, coronary artery
disease (CAD), heart failure, dyslipidaemia, stroke,
smoking, alcohol use and physical inactivity). Schooling
will be quantified in years of formal education. SES will
be evaluated using a Brazilian Scale that considers the
quantity of household goods and the education level of
the household owner, classifying in eight ordinal cat-
egories.28 These categories will be grouped to represent
the upper, medium and lower social classes. Smoking
and alcohol use will be classified in never, current or
former. Physical inactivity will be defined as the individ-
ual who does not perform any physical activity.
Frequency of physical activity per week will be also deter-
mined. The main cause of death and the PMI will be
obtained from the autopsy report.
Anthropometric and visceral fat measurements
Anthropometric and visceral fat measurements will be
obtained by trained persons following standardised
procedures.
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Weight will be measured in kilogram (kg) without
clothes in the supine position using a calibrated elec-
tronic scale. Height will be measured in centimetre
(cm) in the supine position using a stadiometer. After
obtaining these measurements, the body mass index
(BMI) will be calculated by dividing the weight (in kg)
by the square of the height (in metres).29 Neck circum-
ference (NC) will be measured in the region above the
cricoid cartilage.30 The waist circumference (WC) meas-
urement will be performed in the region of the umbil-
icus, and the hip circumference (HC) will be performed
in the largest area on the great trochanters.31 The
abdominal subcutaneous tissue thickness (ASTT) will be
measured at the abdominal midline, 4 cm above the
umbilicus. All measurements will be in cm, using an
inelastic tape.
Individuals with a similar BMI may have different fat
distributions. Thus, the waist-to-hip ratio (WHR) has
been used as an additional measure of adiposity.32 The
WHR and the waist-to-height ratio (WHtR) will be
calculated by dividing the WC by the HC29 and by the
height, respectively.33
A body shape index (ABSI) will be calculated as WC/
(BMI2/3×height1/2) using WC and height in metres, as
suggested by Krakauer and Krakauer34 who determined
that ABSI was a predictor of mortality. In addition, ABSI
has been known to have a stronger association with total
and cardiovascular mortality compared with other
anthropometric measures in older adults.33
The heart and pericardial fat (which consists of epi-
cardial and paracardial fat) will be washed in running
water to remove clots, fixed in 70% alcohol for
1–14 days and weighed. Epicardial fat is located at the
outer wall of the myocardium, and paracardial fat is
located in the mediastinum outside of the parietal peri-
cardium.15 21 Omental, mesenteric, mesocolon and peri-
renal fat will be dissected and weighed (figure 2). All
visceral fat will be weighed using a calibrated electronic
scale, and the measurements will be expressed in grams.
Samples of visceral fat with dimensions of 0.5×1.5 cm
Figure 1 Study outline.
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will be frozen in liquid nitrogen and stored in the
freezer at −80°C, and other samples with dimensions of
1.5×1.5 cm will be fixed in 10% formalin for future
studies.
Standardisation of pericardial fat fixation
To evaluate the effect of different fixation times on peri-
cardial fat weight, we collected pericardial fat from 20
individuals and we weighed the fat in natura and after
fixation in 70% alcohol for 1, 3, 7 and 14 days.
Bland-Altman plots were used to analyse the agreement
between the weights of the fresh and fixed pericardial
fat. We plotted the difference between the weights of the
fresh and fixed pericardial fat against their means,35 and
it was within the agreement limits (figure 3). We also cal-
culated the correlation between the weights of the fresh
and fixed pericardial fat, and they were high for all the
different times (r>0.99).
Evaluation of systemic atherosclerosis
Carotid arteries will be dissected from the base of the
aortic arch and stored in 70% alcohol for 24 hours.
Gelatine will be injected inside the vessel lumen to
prevent artery collapse, and the artery will be further
fixed with 10% formalin. Subsequently, the common and
internal carotid arteries will be cut transversely at 5 mm
intervals,25 and five sections will be selected: (1) a
section with the largest lumen obstruction of the
common carotid artery, (2) the section of the common
carotid artery located 1 cm below the carotid bifurcation,
(3) the section located at the bifurcation, (4) the section
of the internal carotid artery located 1 cm above the
carotid bifurcation and (5) the section containing the
largest lumen obstruction in the internal carotid artery.
These cross-sections will be photographed with a stereo-
microscope (Nikon SMZ 1000; Nikon Inst., New York,
USA); the area will be delimited by the outer vessel wall,
Figure 2 Abdominal visceral fat. (A) Perirenal fat attached to the kidney. (B) ME, OM and MC fat. ME, mesenteric; OM,
omental; MC, mesocolon.
Figure 3 Plots of the difference between the weights of the fresh and fixed pericardial fat against their means. (A) Fresh weight
and after 1 day of fixation; (B) fresh weight and after 3 days of fixation; (C) fresh weight and after 7 days of fixation and (D) fresh
weight and after 14 days of fixation.
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and the lumen area will be measured using an image
processor (Image J) (figure 4). For each segment, the
stenosis index will be calculated by subtracting the lumen
area from the outer area and dividing it by the outer
area. The quotient will be then multiplied by 100.36
The circle of Willis (CW) will be removed from the
base of the brain and processed similarly to the carotid
arteries. Subsequently, the following arteries of the CW
will be cut into 3 mm thick cross-sections: the anterior
cerebral arteries, the anterior communicating artery, the
middle cerebral arteries, the internal carotid arteries
(segments close to the CW), the posterior communicat-
ing arteries, the posterior cerebral arteries and the
basilar artery. The segment with the largest lumen
obstruction from each artery will be photographed using
the stereomicroscope. The stenosis index will be calcu-
lated similarly to the carotid artery.
The left, circumflex, left anterior descending and
right coronary arteries will be dissected and processed
similarly to the carotid and CW arteries. They will be cut
into 5 mm thick sections. The stenosis index of the
largest plaque will be also calculated as previously
described. The presence of myocardial infarction will be
carefully evaluated by a certified pathologist. Lesions will
be classified in acute or chronic myocardial infarcts
according to the criteria of Kumar et al.37 Left ventricu-
lar wall thickness will be measured 1 cm below the
mitral valve in mm.
The number of atherosclerotic plaques in cerebral
and coronary arteries will be counted to describe the
extent of atherosclerotic disease.
We plan to evaluate atheroma plaque characteristics
from the coronary, carotid and cerebral arteries. These
samples will be submitted to the process of dehydration,
diaphanisation and paraffin embedding. Then, the par-
affin block will be cut into 4 µm thickness sections using
a microtome (Leica RM 2145; Leica Microsystems
Brazil). The slides will be stained using H&E and
Verhoeff and photographed using a stereomicroscope.
The evaluation of the plaque composition will be
performed according to the American Heart Association
criteria and classified in types I–VIII.38
The aorta (ascending, thoracic and abdominal) will
be opened longitudinally. The degree of atherosclerosis
and the presence of confluent lesions (those that
extend around the circumference of the aorta) will be
investigated. Plaques will be classified as grade 1 if the
plaques are not confluent and there is no ulcerations
and protrusions, grade 2 if there are confluent areas or/
and an area of ulceration with minimal protrusion and
grade 3 if there are confluent plaques, multifocal ulcera-
tions or protrusions39 (figure 5).
Sample size calculation
The sample size was calculated on the basis of previous
studies using the lowest correlation coefficient found in
the literature from the study of Kortelainen and
Särkioja16 (r=0.109 for the correlation of WC and perire-
nal fat). Assuming a power of 90% and α=0.05, in a two-
tailed test, we will need a sample of 205 individuals. To
better study different age groups, we will include at least
240 individuals in our sample.
DATA ANALYSIS
To describe the sample, we will use mean and SD or
median and IQR for continuous variables and absolute
Figure 4 Measures used for the calculation of the carotid artery stenosis index. (A) Area limited by the outer wall of the vessel.
(B) Lumen area.
Figure 5 Evaluation of the aorta. Grade 3 of atherosclerosis
with ulceration and multifocal protrusion.
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and relative frequencies for categorical variables. If the
distribution is Gaussian, an unpaired t-test will be used to
compare the anthropometric measures (BMI, NC, WC,
HC, WHR, WHtR, ABSI and ASTT) and the weight of vis-
ceral fat (thoracic, abdominal and total) between
genders; otherwise we will use the Mann–Whitney test. We
will use one-way ANOVA to compare these measurements
among age groups (30–49; 50–69; 70–89 and 90 years or
more) and types of myocardial infarction (control, acute,
and chronic) if the distribution is Gaussian, otherwise we
will use the Kruskal-Wallis test. We will use Tukey’s HSD
(honest significant difference) test in post hoc analyses to
determine which mean value is significantly different
among age groups and types of myocardial infarction.
We will use Pearson’s correlation test (for continuous
variables with Gaussian distribution) or Spearman’s
rank correlation coefficient (for continuous distribution
with non-Gaussian distributed or ordinal variables) to
compute the correlation of:
A. Weight of visceral fat with stenosis index in coronary,
cerebral and carotid arteries.
B. Weight of visceral fat with degree of atherosclerosis
in aorta.
C. Weight of visceral fat with number of plaques in cor-
onary and cerebral arteries.
D. Anthropometric measurements with stenosis index in
coronary, cerebral and carotid arteries.
E. Anthropometric measurements with degree of ath-
erosclerosis in aorta.
F. Anthropometric measurements with number of
plaques in coronary and cerebral arteries.
G. Weight of the heart and left ventricular wall thickness
with the stenosis index in coronary arteries.
H. Weight of the heart and left ventricular wall thickness
with number of plaques in coronary arteries.
Linear regression analysis will be used to assess the
association of visceral fat, anthropometric measure-
ments, sociodemographic data and cardiovascular risk
factors with atherosclerosis in coronary, carotid and cere-
bral arteries and will use ordered logistic regression
analysis to assess the association of visceral fat, anthropo-
metric measurements, sociodemographic data and car-
diovascular risk factors with the degree of atherosclerosis
in aorta. Results will be adjusted for age, gender, school-
ing, smoking and physical inactivity; and the weight of
visceral fat will be adjusted for height. The significance
level will be set at 0.05 in two-tailed tests. All analyses will
be performed using the Stata/MP V.14 (StataCorp LP,
College Station, Texas, USA).
STRENGTHS AND LIMITATIONS OF THE STUDY
The main limitation of this study is the absence of clinical
follow-up while the participant was alive. However, previ-
ous studies performed by our group demonstrated good
reliability of our interview compared with a gold-standard
outpatient evaluation.40 41 In addition, the main variables
in this study (eg, atherosclerosis, visceral fat and
anthropometric measurements) will be directly measured
and will not be affected by a lack of follow-up during the
life of the participant. Another limitation is the conveni-
ence sample, since SPAS performs only autopsies on indi-
viduals who died of unknown natural causes of death;
therefore, the sample will not be representative of all
deaths in the city of Sao Paulo.
On the other hand, the structure provided by SPAS
will allow us to get a large sample due to acceptance of
NOK regarding tissue donation and participation in the
study, good conditions of the deceased’s tissue and reli-
able information provided by the NOK. Furthermore,
this study has several strengths. The most important one
will be the large number of participants. In comparison,
most previous autopsy studies evaluated a lower num-
ber of cases, ranging from 30 to 50 individuals,4 16–19
which is probably due to the decreasing number of aut-
opsies performed worldwide.42 Another strength is the
evaluation of older individuals while previous studies
included a larger percentage of younger patients
(Kortelainen and Särkioja:16 mean age 41 years (range:
19–63); Kortelainen and Särkioja:4 35 years (range: 19–
49) and Kortelainen and Särkioja:18 17 years (range: 13–
19)). The short PMI mean of 10.4 hours (4–20 hours) of
the material collected by the BB-BABSG team24 allows
for high-quality material for future genetic and prote-
omic studies. Moreover, our sample will be ethnically
diverse, unlike previous autopsy studies for which the
samples were mostly Caucasian.4 16–18 The present study
also will perform morphometric measures of atheroscler-
otic plaques and objective measurements of visceral fat
that are the gold standard compared with other clinical
and imaging techniques.31 In fact, Kortelainen and
Särkioja18 reported that the autopsy studies have the
advantage of being able to measure the whole deposit of
visceral fat and allows for complete assessment of the
coronary tree. Additionally, our study will evaluate ath-
erosclerosis not only in coronary arteries but also in the
aorta, cerebral and carotid arteries, which is a unique
aspect compared with other studies. Furthermore, most
of the previous autopsy studies evaluated only abdominal
visceral fat, while we also will evaluate pericardial fat.
Finally, we will use a unique autopsy service that
already supported a variety of pathological projects to
gather a high-quality and diverse tissue collection of
arteries and visceral fat. This service also provides a com-
prehensive postmortem clinical evaluation. A large
number of samples can be collected due to the great
number of autopsies performed in our service. The
stored fat and arterial samples will be an outstanding
opportunity for future collaborative studies that will
advance the understanding of the relationship between
atherosclerosis pathophysiology and adiposity.
DISSEMINATION
After being informed about this study, the NOK of the
deceased will sign a written informed consent. Results
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will be submitted for publication in a peer-reviewed
journal and also presented at national and international
conferences.
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